Article Details

Protagonist Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference 2025

Retrieved on: 2024-12-19 21:16:02

Tags for this article:

Click the tags to see associated articles and topics

Protagonist Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference 2025. View article details on hiswai:

Excerpt

Icotrokinra (JNJ-2113, formerly PN-235) is the first targeted oral peptide ... Biotechnology: Biological Products (No Diagnostic Substances). Health ...

Article found on: quantisnow.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo